Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Budgets should evolve with life. This intro highlights clear indicators that it’s time to revise your plan and adjust priorities.
23,287 articlesGSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Crypto investment products logged $619 million in net inflows last week amid Iran tensions, with an early surge follo...
Oracle confronts a heavy debt burden and sweeping layoffs as it presses ahead with a three-step transformation, raisi...
Oracle’s $523 billion backlog raises timing concerns as capex surges. cnbc’s deirdre bosa warns that the chip upgrade...
Crexi partners with Dwellsy to add residential rental data to its analytics platform, expanding into the housing mark...
A major family-office investor has increased its position in Middleby as the company prepares a spin-off. This move o...
In March 2026, investors weigh IMAX, SHARKNINJA, and SONOS as each pushes growth through screens, margins, and softwa...
Revolut has begun launching its UK bank after a regulator lifted license restrictions. The phased migration will roll...
Solana is under renewed selling pressure as negative funding rates persist and on-chain inflows surge. Analysts warn ...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
A veteran Wall Street analyst sees Delta Air Lines climbing roughly 50% in 2026, backed by fuel-efficiency gains and ...
United Airlines faces near term pressure from higher fuel costs, yet the Street remains optimistic with a consensus t...